Nucci M, Anaissie E. Fusarium infections in immunocompromised patients. Clin Microbiol Rev. 2020;33(3):e00112–20.

Google Scholar 

Guarner J, Brandt ME. Fusarium infections: clinical features and therapy. Clin Microbiol Rev. 2021;34(3):e00053–19.

Google Scholar 

The European Committee on Antimicrobial Susceptibility Testing. Overview of antifungal ecoffs and clinical breakpoints for yeasts, moulds and dermatophytes using the EUCAST e.def 7.4, e.def 9.4 and e.def 11.0 procedures. Version 5.0, 2024. http://www.eucast.org. accessed: 24.03.2025.

Sutton DA, et al. Antifungal susceptibility patterns of fusarium species: A review. Mycoses. 2019;62(6):471–8.

Google Scholar 

Schwartz RA, et al. Trauma-Related fusarium infections in immunocompetent hosts. Mycopathologia. 2017;182(6):729–34.

Google Scholar 

Husain S, Alexander BD. Invasive fusariosis: insights into management. J Infect Dis. 2022;225(4):637–46.

Google Scholar 

Al-Hatmi Abdullah MS, et al. Epidemiology of fusarium species and its impact on human health. J Clin Microbiol. 2019;57(9):e00324–19.

Google Scholar 

Al-Hatmi Abdullah MS et al. Antifungal susceptibility testing of fusarium: A practical approachj. Fungi 2017, 3, 19; https://doi.org/10.3390/jof3020019

Pagano L, et al. Clinical efficacy of voriconazole in fusarium infections. Antimicrob Agents Chemother. 2020;64(4):e01934–19.

Google Scholar 

Snyder JW, et al. Fusarium resistance patterns: A global perspective. Infect Dis Clin North Am. 2021;35(4):903–18.

Google Scholar 

Taj-Aldeen SJ, et al. In vitro resistance of clinical fusarium species to amphotericin B and voriconazole using the EUCAST antifungal susceptibility method. Diagn Microbiol Infect Dis. 2016;85:438–43.

Article  CAS  PubMed  Google Scholar 

Castillo- Castañeda A, et al. Transcriptional response of fusarium oxysporum and Neocosmospora Solani challenged with amphotericin B or. Posaconazole Microbiol. 2020;166:936–46.

Article  Google Scholar 

Pappas PG, et al. Antifungal resistance in Non-Candida pathogens: A growing concern. Clin Infect Dis. 2022;75(5):893–9.

Google Scholar 

Crosby EC, et al. Pediatric fusariosis after traumatic injury: case series and review. Pediatr Infect Dis J. 2018;37(2):151–5.

Google Scholar 

Johnson MD, Perfect JR. Antifungal therapy for Non-Aspergillus molds. Clin Infect Dis. 2020;71(5):1236–45.

Google Scholar 

Hoenigl M, et al. Fungal pathogen resistance mechanisms and clinical relevance. Front Microbiol. 2021;12:678345.

Google Scholar